Worth a Read
The Discount Goes to Market
SK Hynix listed on Nasdaq alongside its Seoul shares — CNBC asks whether a US listing can narrow the 'Korea discount' that keeps it cheaper than Micron despite leading in HBM.
Source: CNBC (cnbc.com) Read the original →
SK Hynix's Nasdaq debut raised $26.5 billion, priced at $149 per ADR — a 2.9% premium to its Seoul-listed shares, and oversubscribed on the way there. That's a striking outcome for a stock that CNBC frames as chronically underpriced: SK Hynix trades around 4.8x 12-month forward earnings versus 6.6x for Micron and an industry median near 29.8x per LSEG data, despite leading both in HBM, the high-bandwidth memory that feeds AI accelerators.
The piece works through why the "Korea discount" persists even for a clear technology leader. Futurum's Rolf Bulk expects the listing to narrow the gap without closing it, reframing the real debate as capacity rather than market share as SK Hynix's HBM position likely eases from roughly 57% toward the low-40s. eToro's Wong points to access and familiarity, not fundamentals, as the wedge — the ADR pop didn't touch the gap to Micron, even with both stocks up roughly 240-250% year-to-date. KB Financial's Kim ties the listing to easier US access, Rayliant's Wool calls SK Hynix a victim of its own success since HBM demand outran its supply, and S&P's Cheong notes most of its ₩50-70 trillion annual capex comes from internal cash flow — the listing's value is the access, not the capital.
The core idea A Nasdaq listing can buy SK Hynix easier access to US capital and investor familiarity, but the CNBC piece is clear that access isn't the same lever as valuation. The stock popped on debut; the multiple gap to Micron didn't move. That split — governance and access on one side, earnings and supply on the other — is the actual shape of the Korea discount.
Where it fits
Closelook covered the same news the same day from a different angle: our Pulse piece on three ways to own the memory supercycle and the Memory/HBM Pulse dashboard both work the trio's HBM capacity and pricing anatomy. CNBC's angle is narrower and complementary: it's about the ADR mechanics and whether a Korea discount rooted in access and governance can close through a US listing alone. Whether it narrows further from here, or holds at arm's length from the earnings story, is a probability to track, not a call to make now.
Worth a Read points you to another writer's published work; the synthesis above, and any errors in it, are Closelooknet's, not the source's. Closelooknet publishes a market diary, not investment advice — circumstances differ; consult a licensed advisor before acting.